09.06.2024

Vienna, June 05, 2024

Participants from Germany, Gabon, Cameroon, Austria, the Netherlands and Switzerland were represented in person.

Just over a year into the project, the first significant successes have been achieved. A master protocol for the planned clinical trial was submitted to the European Medicines Agency (EMA). This harmonized protocol makes it possible to conduct a multi-center clinical trial in Gabon, Cameroon, the Democratic Republic of the Congo and Tanzania for four different helminth (worm) diseases.

During the two-day meeting, the next steps of the large adaptive clinical trial were discussed. Among other things, important steps that need to be taken for the protocol to be accepted in the target countries were discussed. There were also presentations on topics such as capacity building, virtual microscopy and database and data management.

For more information on the second General Assembly of eWHORM click here:

https://ewhorm.org/news/ewhorm-partners-gather-in-vienna-austria-for-their-first-progress-meeting